SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

BIENAIME JEAN JACQUES

(Last)

(First)

(Middle)

C/O BIOMARIN PHARMACEUTICAL INC.

770 LINDARO ST.

(Street)

SAN RAFAEL

94901

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
BIOMARIN PHARMACEUTICAL INC [ BMRN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	Chief Executive Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/28/2014

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/28/2014	03/28/2014	M		2,000	A	$12.99	48,740	I	Shares held by Bienaime Family Trust⁽¹⁾
Common Stock								194,520	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option (right to buy Common Stock)	$12.99	03/28/2014	03/28/2014	M			2,000	11/11/2006	05/10/2016	Common Stock	2,000	$0	84,500	I	Shares held by Bienaime Family Trust
Stock Option (right to buy Common Stock)	$12.99							11/11/2006	05/10/2016	Common Stock	10,000		10,000⁽²⁾	I	Held in irrevocable trust for Guillaume Bienaime⁽³⁾
Stock Option (right to buy Common Stock)	$12.99							11/11/2006	05/10/2016	Common Stock	10,000		10,000⁽²⁾	I	Held in irrevocable trust for Pierre Bienaime⁽³⁾
Stock Option (right to buy Common Stock)	$12.99							11/11/2006	05/10/2016	Common Stock	10,000		10,000⁽²⁾	I	Held in irrevocable trust for Paul Bienaime⁽³⁾
Stock Option (right to buy Common Stock)	$12.99							11/11/2006	05/10/2016	Common Stock	10,000		10,000⁽²⁾	I	Held in irrevocable trust for Marc Bienaime⁽³⁾
Stock Option (right to buy Common Stock)	$12.99							11/11/2006	05/10/2016	Common Stock	20,000		20,000⁽²⁾	I	Held in irrevocable trust for Aurelie Mitsuki Bienaime and Anais Kimio Bienaime⁽³⁾

Explanation of Responses:

1. The reporting person and his spouse act as trustees for the Bienaime Family Trust.

2. Form 4s filed by the reporting person between March 4, 2013 and February 24, 2014 (the "Prior Forms 4s") inadvertently reported as common stock indirectly owned by the reporting person on Table I options to purchase an aggregate of 60,000 shares held in trusts for the reporting person's children (the "Options") while certain of the Prior Form 4s inadvertently omitted the Options from Table II. The reporting person gifted the Options to his children's trusts on October 19, 2012 and the transactions were reported on the Form 5 filed by the reporting person on February 14, 2013. As the Options have not been exercised and remain derivative securities indirectly owned by the reporting person, the Options should not have been included in Table I in the Prior Form 4s and have been correctly listed as derivative securities on Table II of this Form 4.

3. The reporting person's spouse is trustee of each child's trust.

Remarks:

	/s/ Laura Randall Woodhead, Attorney-in-Fact	04/01/2014
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.